5-Year UTARNG Lab Services Blanket Purchase Agreement (BPA)
The Utah Army National Guard (UTARNG) is seeking a 5-year Blanket Purchase Agreement (BPA) for medical laboratory services to support its Individual Medical Readiness program. The solicitation, numbered W911YP25RA005, requires a local laboratory services company located in Davis, Salt Lake, or Utah counties to perform daily pickup of blood and urine samples Monday through Thursday, with all samples tested within 24 hours of receipt. The contract will be awarded using Lowest Price Technically Acceptable (LPTA) evaluation criteria, with offerors required to complete a mock lab services scenario pricing form to demonstrate their pricing competitiveness. Proposals are due by 0800 MST on March 25, 2025, and all respondents must be registered in the System for Award Management (SAM.gov) under NAICS code 621511. The solicitation emphasizes that only proposals from registered small businesses will be considered, and vendors must demonstrate previous experience with similar medical laboratory service projects.
This requirement is a total small business set-aside with a small business size standard of $41.5 million, targeting medical laboratory service providers. The BPA will cover five 1-year ordering periods, with individual service calls or Government Purchase Card purchases made against the established agreement. While no specific total contract value is mentioned, the solicitation includes a detailed spreadsheet showing historical usage data for 57 different types of laboratory tests. The place of performance is the Utah Army National Guard Joint Force Headquarters Facility located at 12953 S Minuteman Drive in Draper, Utah. Contractors will be required to provide comprehensive medical testing services, including metabolic panels, lipid panels, CBC testing, and drug screening, while maintaining compliance with OSHA, HIPAA, and CLIA standards. Payment will be processed electronically through Wide Area Workflow (WAWF), with no advancement of charges authorized and all invoices subject to government verification.
W911YP25RA005 Department of the Army Utah Army National Guard
2/25/25, 4:24 PM Q301--Indianapolis Reference Laboratory Testing
The Veterans Health Administration (VHA), Network Contracting Office (NCO) 10 is seeking Reference Laboratory Testing Services for the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana. The solicitation, planned for release on February 26, 2024, will be an unrestricted open market procurement under NAICS code 621511 for Medical Laboratories. Interested vendors must be registered in SAM.gov with an active profile that includes the specified NAICS code. Responses will be evaluated using a comparative approach governed by FAR Parts 12 and 13, with specific evaluation criteria to be detailed in the full solicitation. The closing date for quote submissions is March 12, 2025, at 1:00 PM ET, with a structured question period during which vendors can submit inquiries that will be answered via solicitation amendment within three business days.
The contract will be structured as an Indefinite Delivery Indefinite Quantity (IDIQ) with a firm fixed price, targeting medical laboratory services with a size standard of $41.5 million. No specific set-aside has been designated for this opportunity, making it open to all qualified vendors. While the precise award value is not specified in the pre-solicitation notice, the NAICS size standard suggests potential for significant contract value. The contract will cover reference laboratory testing services, though specific volumes or exact service requirements will be detailed in the full solicitation. Vendors should note that no site visit will be conducted, and all communication and document transmission will occur through SAM.gov, with the contract specialist Jessica Bryant serving as the primary point of contact for this procurement.
36C25025Q0230 Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10
2/25/25, 5:05 PM Oncology breast testing
The Defense Health Agency (DHA), specifically the Northeastern Healthcare Operations Contracting Division, is seeking a source to provide advanced oncology testing services for Augusta Military Medical Center's Pathology Department. The primary objective is to procure genetic molecular analysis services that can deliver diagnostic genetic and biological tumor information for breast, colon, and prostate cancer types. The agency specifically identifies the Oncotype DX test as the preferred multigene assay capable of predicting chemotherapy treatment effects and prognostic disease outcomes. While the DHA intends to award a firm fixed price contract on a sole source basis to Genomic Health, Inc., they are open to alternative vendors who can demonstrate comparable capabilities. The pre-solicitation notice was posted on February 21, 2025, with responses due by March 20, 2025, and potential vendors are encouraged to submit substantiated and validated information about their testing capabilities.
The pre-solicitation notice indicates no specific set-aside designations for this contract opportunity. The potential award will be structured as a firm fixed price contract, targeting the Reference Laboratory Testing category under NAICS code 621511 for Medical Laboratories. Genomic Health, Inc., located in Redwood City, California, is currently the identified sole source provider, with a CAGE code of 37AM2. While specific award values are not disclosed in the notice, the contract will support the Anatomic Pathology Section's requirement for advanced oncological testing services. The primary evaluation criteria will focus on a vendor's ability to provide a multigene assay that can both predict chemotherapy treatment effectiveness and provide prognostic insights into disease outcomes, with a specific focus on breast cancer testing methodologies.
HT001425SS0001 Defense Health Agency
2/21/25, 3:19 PM SOURCES SOUGHT - LAB & PATHOLOGY SERVICES FOR OKLAHOMA AREA IHS
The Indian Health Service (IHS), a component of the Department of Health and Human Services, is conducting a sources sought notice for laboratory and pathology services across Oklahoma Area facilities. The solicitation seeks to identify businesses capable of providing comprehensive laboratory testing services for 12 health centers and hospitals serving approximately 170,000 users across 39 tribes. Vendors must demonstrate specific capabilities in specimen collection, transport, testing, reporting, and laboratory consultation services, with a requirement to complete 85% of routine testing within 24 hours. The government will evaluate capability statements based on detailed submissions that demonstrate direct experience, technical capacity, and ability to meet complex laboratory service requirements. Interested parties must submit their responses via email to Contract Specialist Edson Yellowfish by 12:30 PM CST on March 7, 2025, with a maximum submission length of five pages.
The sources sought notice gives preference to Indian Economic Enterprises (IEE) and strongly encourages Indian Small Business Economic Enterprises (ISBEEs) to respond. While no specific award value is mentioned, the contract requires extensive service capabilities including two daily specimen pickups, CLIA certification, electronic interface implementation, and monthly/quarterly on-site pathologist services at multiple facilities. The contractor must provide 24/7 emergency laboratory services covering clinical testing, surgical pathology, cytology, histology, and necropsy services. Respondents must be registered in the System for Award Management (SAM) and provide comprehensive documentation including company information, socioeconomic status, unique identifiers, and contact details. The solicitation is classified under NAICS code 621511 for Medical Laboratories and PSC code Q301 for Reference Laboratory Testing, indicating a specialized medical service procurement.
246-25-Q-0036 Department of Health and Human Services Indian Health Service
2/25/25, 10:58 PM Performance Enhancing Drug (PED) Testing
The United States Special Operations Command is seeking a laboratory accredited with the World Anti-Doping Agency (WADA) to conduct Performance Enhancing Drug (PED) testing for human urine specimens. The contract requires comprehensive analysis of anabolic steroids as defined in the Designer Anabolic Steroid Control Act of 2014, including personnel, equipment, supplies, facilities, materials, and supervision necessary for testing. Potential vendors must demonstrate WADA accreditation and capability to analyze urine specimens for anabolic steroids, conduct Isotope Ratio Mass Spectrometry tests, and provide scientific/forensic interpretation expertise. The Sources Sought notice indicates that interested laboratories must submit capability statements by 11:00 AM EST on March 3, 2025, via email to the Contract Specialist Noel Perez and Contracting Officer Jonathan Long. Evaluation will focus on technical capabilities, laboratory accreditation, and specific testing methodologies aligned with WADA standards.
The pre-solicitation notice does not indicate any specific set-aside designations for this procurement. The contract falls under NAICS category 541380 for Testing Laboratories and Services, with a $19.0M size standard. The anticipated contract structure includes a 12-month base period with four additional one-year ordering periods, suggesting a potential multi-year engagement. While no specific award value is explicitly stated, the comprehensive testing requirements and specialized nature of the work suggest a significant potential contract value. The procurement is specifically targeted at laboratories with advanced scientific capabilities in performance-enhancing drug detection, indicating a highly specialized and technical requirement. The government has emphasized that this Sources Sought notice is informational and does not constitute a formal solicitation, with no contract to be awarded based on the initial responses.
H92239-25-R-0009 United States Special Operations Command
2/21/25, 2:12 PM